BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mosterd CM, Kanbay M, van den Born BJH, van Raalte DH, Rampanelli E. Intestinal microbiota and diabetic kidney diseases: the Role of microbiota and derived metabolites inmodulation of renal inflammation and disease progression. Best Pract Res Clin Endocrinol Metab 2021;35:101484. [PMID: 33546983 DOI: 10.1016/j.beem.2021.101484] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Tuttle KR, Agarwal R, Alpers CE, Bakris GL, Brosius FC, Kolkhof P, Uribarri J. Molecular Mechanisms and Therapeutic Targets for Diabetic Kidney Disease. Kidney Int 2022:S0085-2538(22)00436-7. [PMID: 35661785 DOI: 10.1016/j.kint.2022.05.012] [Reference Citation Analysis]
2 Chen W, Zhang M, Guo Y, Wang Z, Liu Q, Yan R, Wang Y, Wu Q, Yuan K, Sun W. The Profile and Function of Gut Microbiota in Diabetic Nephropathy. Diabetes Metab Syndr Obes 2021;14:4283-96. [PMID: 34703261 DOI: 10.2147/DMSO.S320169] [Reference Citation Analysis]
3 Zhang M, Yang L, Zhu M, Yang B, Yang Y, Jia X, Feng L. Moutan Cortex polysaccharide ameliorates diabetic kidney disease via modulating gut microbiota dynamically in rats. Int J Biol Macromol 2022;206:849-60. [PMID: 35307460 DOI: 10.1016/j.ijbiomac.2022.03.077] [Reference Citation Analysis]
4 Liu J, Gao L, Fu B, Yang H, Zhang L, Che S, Xu Y, Du X, Liu Z, Xue Y, Lv C, Huang Y, Wang B, Gao S, Xing Y, Yuan X. Efficacy and safety of Zicuiyin decoction on diabetic kidney disease: A multicenter, randomized controlled trial. Phytomedicine 2022;100:154079. [DOI: 10.1016/j.phymed.2022.154079] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Tougaard NH, Frimodt-møller M, Salmenkari H, Stougaard EB, Zawadzki AD, Mattila IM, Hansen TW, Legido-quigley C, Hörkkö S, Forsblom C, Groop P, Lehto M, Rossing P. Effects of Butyrate Supplementation on Inflammation and Kidney Parameters in Type 1 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial. JCM 2022;11:3573. [DOI: 10.3390/jcm11133573] [Reference Citation Analysis]
6 Bian J, Liebert A, Bicknell B, Chen XM, Huang C, Pollock CA. Faecal Microbiota Transplantation and Chronic Kidney Disease. Nutrients 2022;14:2528. [PMID: 35745257 DOI: 10.3390/nu14122528] [Reference Citation Analysis]
7 Hua Q, Han Y, Zhao H, Zhang H, Yan B, Pei S, He X, Li Y, Meng X, Chen L, Zhong F, Li D. Punicalagin alleviates renal injury via the gut-kidney axis in high-fat diet-induced diabetic mice. Food Funct 2022;13:867-79. [PMID: 34989745 DOI: 10.1039/d1fo03343c] [Reference Citation Analysis]
8 Mertowska P, Mertowski S, Wojnicka J, Korona-Głowniak I, Grywalska E, Błażewicz A, Załuska W. A Link between Chronic Kidney Disease and Gut Microbiota in Immunological and Nutritional Aspects. Nutrients 2021;13:3637. [PMID: 34684638 DOI: 10.3390/nu13103637] [Reference Citation Analysis]